Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 1;106-B(5):425-429.
doi: 10.1302/0301-620X.106B5.BJJ-2023-1381.

Controversies in orthopaedic oncology

Lee M Jeys  1 Joachim Thorkildsen  2 Vineet Kurisunkal  1 Ajay Puri  3 Pietro Ruggieri  4 Matthew T Houdek  5 Richard A Boyle  6 Walid Ebeid  7 Eduardo Botello  8 Guy V Morris  1 BOOM Consensus Scientific CommitteeMinna K Laitinen  9 BOOM Consensus Scientific CommitteeAdesegun Abudu  1 Keisuke Ae  10 Manish Agarwal  11 Vivek Ajit Singh  12 Toru Akiyama  13 Jose I Albergo  14 John Alexander  15 Bugra Alpan  16 Ahmed Aoude  17 Apichat Asavamongkolkul  18 William Aston  19 Thomas Baad-Hansen  20 Tessa Balach  21 Joseph Benevenia  22 Peter Bergh  23 Nicholas Bernthal  24 Odion Binitie  25 Michele Boffano  26 Jos Bramer  27 Harriet Branford White  28 Bernadette Brennan  29 Jorge Cabrolier  30 Jose A Calvo Haro  31 Domenico A Campanacci  32 Rodrigo Cardoso  33 Richard Carey Smith  34 Nicolas Casales Fresnga  35 Jose M Casanova  36 Oscar Ceballos  30 Chung M Chan  37 Yang-Guk Chung  38 Miguel A Clara-Altamirano  39 Gillian Cribb  40 Solomon Dadia  41 Dietmar Dammerer  42 Marieke de Vaal  43 Javier Delgado Obando  44 Shaneel Deo  45 Claudia Di Bella  46 Davide M Donati  47 Makoto Endo  48 Levent Eralp  49 Bulent Erol  50 Scott Evans  1 Will Eward  51 Fabrice Fiorenza  52 Joao Freitas  36 Philipp T Funovics  53 Marcos Galli Serra  54 Michelle Ghert  55 Kanishka Ghosh  56 Luis C Gomez Mier  57 Jesus Gomez Vallejo  58 Anthony Griffin  59 Ashish Gulia  60 Maurice Guzman  61 Jendrik Hardes  62 John Healey  63 Adriana Hernandez  64 Asle Hesla  65 Chindanai Hongsaprabhas  66 Francis Hornicek  67 Keith Hosking  68 Shintaro Iwata  69 Jake Jagiello  70 Luke Johnson  71 Andy Johnston  72 Min Joo  73 Paul Jutte  74 Bilal Kapanci  75 Zeeshan Khan  76 Hiroshi Kobayashi  77 Yehuda Kollender  78 Sebastian Koob  79 Daniel Kotrych  80 Louis-Romee Le Nail  81 Pawel Legosz  82 Burkhard Lehner  83 Andreas Leithner  84 Valerae Lewis  85 Peng Lin  86 Francisco Linares  87 Santiago Lozano Calderon  88 Ashish Mahendra  89 Ferdiansyah Mahyudin  90 Eric Mascard  91 Jean-Camille Mattei  92 Louise McCullough  93 Manuel R Medellin Rincon  94 Rhidian Morgan-Jones  95 Diego J Moriel Garcesco  96 Sophie Mottard  97 Robert Nakayama  98 Prashant Narhari  99 Gary O'Toole  100 Oliveira Vania  101 André Olivier  102 Mohamed Omar  103 Eduardo Ortiz-Cruz  104 Harzem Ozger  105 Korhan Ozkan  106 Emanuela Palmerini  107 Panayiotis Papagelopoulos  108 Michael Parry  1 Sam Patton  109 Michael M Petersen  110 Gerard Powell  46 Mark Puhaindran  37 Anand Raja  111 Raja B Rajasekaran  112 Lauris Repsa  113 Mickael Ropars  114 Andrea Sambri  115 Thomas Schubert  116 Ahmad Shehadeh  117 Geoffrey Siegel  118 Scott Sommerville  119 Andre Spiguel  120 Jonathan Stevenson  1 Gwen Sys  121 Thomas Temple  67 Frank Traub  122 Hiroyuki Tsuchiya  123 Juan Valencia  124 Michel Van de Sande  125 Gualter Vaz  126 Roberto Velez Villa  127 Oleg Vyrva  128 Hazem Wafa  129 Wan I Wan Faisham Numan  130 Edward Wang  131 David Warnock  132 Joel Werier  133 Kwok-Chuen Wong  134 Yamamoto Norio  123 Ye Zhaoming  86 Suraya Zainul Abidin  135 Tomas Zamora  136 Juan P Zumarraga  137 Ghaith Abou-Nouar  138 Carsten Gebert  139 R L Randall  140
Affiliations

Controversies in orthopaedic oncology

Lee M Jeys et al. Bone Joint J. .

Abstract

Chondrosarcoma is the second most common surgically treated primary bone sarcoma. Despite a large number of scientific papers in the literature, there is still significant controversy about diagnostics, treatment of the primary tumour, subtypes, and complications. Therefore, consensus on its day-to-day treatment decisions is needed. In January 2024, the Birmingham Orthopaedic Oncology Meeting (BOOM) attempted to gain global consensus from 300 delegates from over 50 countries. The meeting focused on these critical areas and aimed to generate consensus statements based on evidence amalgamation and expert opinion from diverse geographical regions. In parallel, periprosthetic joint infection (PJI) in oncological reconstructions poses unique challenges due to factors such as adjuvant treatments, large exposures, and the complexity of surgery. The meeting debated two-stage revisions, antibiotic prophylaxis, managing acute PJI in patients undergoing chemotherapy, and defining the best strategies for wound management and allograft reconstruction. The objectives of the meeting extended beyond resolving immediate controversies. It sought to foster global collaboration among specialists attending the meeting, and to encourage future research projects to address unsolved dilemmas. By highlighting areas of disagreement and promoting collaborative research endeavours, this initiative aims to enhance treatment standards and potentially improve outcomes for patients globally. This paper sets out some of the controversies and questions that were debated in the meeting.

PubMed Disclaimer

Conflict of interest statement

A. Puri is a member of the editorial board of The Bone & Joint Journal. P. Ruggieri reports consulting fees from Exactech and Stryker, unrelated to this study. M. T. Houdek reports consulting fees from Link Orthopedics, unrelated to this study. E. Botello reports consulting fees, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, and support for attending meetings and/or travel from Zimmer Biomet, all of which are unrelated to this study. G. V. Morris reports consulting fees, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, and support for attending meetings and/or travel from Implantcast, all of which are unrelated to this study.

References

    1. Enneking WF . History of orthopedic oncology in the United States: progress from the past, prospects for the future . Cancer Treat Res . 2009 ; 152 : 529 – 571 . 10.1007/978-1-4419-0284-9_32 20213414
    1. No authors listed . Bone sarcoma statistics . Cancer Research UK . 2023 . https://www.cancerresearchuk.org/health-professional/cancer-statistics/s... ( date last accessed 20 February 2024 ).
    1. Evaniew N , Nuttall J , Farrokhyar F , Bhandari M , Ghert M . What are the levels of evidence on which we base decisions for surgical management of lower extremity bone tumors? Clin Orthop Relat Res . 2014 ; 472 ( 1 ): 8 – 15 . 10.1007/s11999-013-3311-1 24081669
    1. Kantrowitz A . The science court experiment . Science . 1976 ; 194 ( 4260 ): 6 . 10.1126/science.194.4260.6-a 17793045
    1. Schneider PJ , Evaniew N , McKay P , Ghert M . Moving forward through consensus: a modified Delphi approach to determine the top research priorities in orthopaedic oncology . Clin Orthop Relat Res . 2017 ; 475 ( 12 ): 3044 – 3055 . 10.1007/s11999-017-5482-7 28856514

Publication types